Sectors
SNTI
Senti Biosciences Holdings, Inc.
0.38
2 x 0.27
2 x 0.49
bid
ask
+
0.00
0.34%
2 @ 06:32 PM
0.38 -0.00 (0.19%)
| Ytd | -63.63% | |
| 1y | -74.27% |
0.36
day range
0.38
0.33
52 week range
2.88
| Open | 0.36 | Prev Close | 0.38 | Low | 0.36 | High | 0.38 | Mkt Cap | 11.78M |
| Vol | 23.98K | Avg Vol | 262.69K | EPS | -1.69 | P/E | N/A | Forward P/E | -5.33 |
| Beta | 2.75 | Short Ratio | 3.27 | Inst. Own | 23.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.62 | 200-d Avg | 1.00 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 17.00K | ||
| Revenues (USD) | 17.00K | ||
| Gross Profit | 17.00K | ||
| Operating Expenses | 14.51M | ||
| Research and Development Expense | 7.77M | ||
| Selling, General and Administrative Expense | 6.74M | ||
| Operating Income | -14.49M | ||
| Net Income | -12.75M | ||
| Net Income Common Stock | -12.75M | ||
| Net Income Common Stock (USD) | -12.75M | ||
| Consolidated Income | -12.75M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -12.75M | ||
| Earning Before Interest & Taxes (USD) | -12.75M | ||
| Weighted Average Shares | 31.14M | ||
| Weighted Average Shares Diluted | 31.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.89M | ||
| Cash and Equivalents (USD) | 7.89M | ||
| Current Assets | 13.01M | ||
| Property, Plant & Equipment Net | 18.67M | ||
| Total Assets | 33.10M | ||
| Debt Current | 7.49M | ||
| Total Debt | 20.23M | ||
| Current Liabilities | 15.77M | ||
| Debt Non-Current | 12.74M | ||
| Total Liabilities | 36.51M | ||
| Accumulated Retained Earnings (Deficit) | -375.54M | ||
| Shareholders Equity | -3.40M | ||
| Shareholders Equity (USD) | -3.40M | ||
| Assets Non-Current | 20.10M | ||
| Total Debt (USD) | 20.23M | ||
| Deferred Revenue | 1.95M | ||
| Liabilities Non-Current | 20.74M | ||
| Trade and Non-Trade Payables | 2.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 667.00K | ||
| Net Cash Flow from Financing | 9.68M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.57M | ||
| Issuance (Repayment) of Debt Securities | 9.70M | ||
| Net Cash Flow from Operations | -14.25M | ||
| Share Based Compensation | 1.05M | ||